Author
|
Article types
|
Year
|
N of
patients
|
Incidence (%)
|
Age (years)
|
Sex (F)
|
In-hospital mortality
(%)
|
Causes of death
|
Follow-up
(mo)
|
Okita Y et al [12]
|
RS
|
2021
|
50
|
13.1
|
68.1 ± 9.2
|
NA
|
14 (28%)
|
stroke 8
|
5-y survival (75.2 ± 12.5%)
10-y survival (60.5 ± 23.4%)
|
Sugiyama K et al [13] |
RS |
2021 |
19 |
21 |
69 (39–84) |
2 |
2
(10.5%) |
extensive cerebral infarction |
NA |
Gomibuchi T et al [14] |
RS |
2021 |
42 |
21.3 |
64.9 ± 11.1 |
22 |
2 (4.8%) |
NA |
NA |
Sasaki H et al [8] |
RS |
2020 |
9 |
7.1 |
66.2±12.9 |
8 |
0 |
0 |
24 (all survival) |
Shimura S et al [15] |
RS |
2020 |
16 |
7.7 |
63 (32-83) |
8 |
1
(6.3%) |
severe cerebral edema |
101±7 |
Luehr M et al[16] |
RS |
2016 |
23 |
6.5 |
66.3(55.2–69.9) |
5 |
3
(13.0%) |
cerebral haemorrhag 2, MOF 1 |
15.2
(4.8–34.1) |
Di Eusanio M et al [3]
|
RS
|
2013
|
99
|
7.5
|
63.1±13.7 62.8±12.2
|
NA
|
33 (33.3%)
|
NA
|
median 36
5-y survival: 67.1% (CVA), 57.1% (coma)
|
Morimoto N et al [5]
|
RS
|
2011
|
41
|
26.1
|
67.3±10.0, 69.7±11.5
|
16
|
6 (14.6%)
|
large hemispheric infarction,
|
57.6 (1.2–136.8)
5-y survival 65%±8%
10-y survival 59%±9%
|
Nakamura Y [17] |
RS |
2011 |
10 |
22.4 |
69±9 (57-84) |
5 |
0 |
0 |
18±5 |
Tsukube T et al [18]
|
RS
|
2011
|
24
|
14.9
|
71.9 (44-91)
|
18
|
4(16.7%)
|
Aortic rupture 1, AMI 1, massive brain edema 2
|
34.5±25.1
3 years cumulative survival rate 71.8%
|
Estrera AL et al [9]
|
RS
|
2006
|
14
|
19
|
56 (43-73)
|
6
|
1 (7%)
|
small bowel necrosis
|
18.5
1-y survival 81.3%
5-y survival 58.0%
|
Tanaka H et al [19]
|
RS
|
2005
|
16
|
25.3
|
71.6±7.7
|
10
|
7 (43.7%)
|
severe brain demage
|
25.2±21 (2-56)
4-y survival 50.1%
|
Total |
RS |
2005
-2021
|
363
(15.5%)
|
15.9 |
65.7±13 (32-91) |
100 |
73 (20.1%) |
neurological damage (n = 28), MOF (n = 1), aortic
rupture (n = 1), AMI (n = 1), small bowel necrosis (n = 1) |
40.1 ± 37.6
5y survival 65.3 ±
11%
|